Ceftriaxone-Resistant Gonorrhea — China, 2022

Xiaoyu Zhu,Yue Xi,Xiangdong Gong,Shaochun Chen

DOI: https://doi.org/10.15585/mmwr.mm7312a2

2024-03-30

MMWR Morbidity and Mortality Weekly Report

Abstract:This report describes increases in the prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae in China.

public, environmental & occupational health

What problem does this paper attempt to address?

Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17).

Jing Yan,Juan Xue,Yan Chen,Shi Chen,Qiang Wang,Chuanling Zhang,Shenghai Wu,Huoyang Lv,Yunsong Yu,Stijn van der Veen

DOI: https://doi.org/10.1093/jac/dky412

2019-01-01

Journal of Antimicrobial Chemotherapy

Abstract:Objectives: Development of resistance in Neisseria gonorrhoeae to ceftriaxone monotherapy or ceftriaxone plus azithromycin dual therapy is a global public health concern. The aim of this study was to analyse the trend in antimicrobial resistance in Hangzhou, China, over the period 2015-17. Methods: In total, 379 clinical isolates were collected from seven hospitals and antimicrobial susceptibility was determined using the agar dilution method. Isolates showing resistance to ceftriaxone, azithromycin or cefixime were analysed for the presence of resistance determinants. STs were determined with the N. gonorrhoeae multi antigen sequence typing (NG-MAST) method and phylogenetic analysis and strain clustering was determined using porB and tbpB sequences. Results: Ceftriaxone resistance, decreased susceptibility to ceftriaxone and azithromycin resistance were observed in 3%, 17% and 21% of the isolates, respectively. This resulted in 5% of the isolates showing both decreased susceptibility to ceftriaxone and azithromycin resistance. Importantly, resistance levels to ceftriaxone and azithromycin increased over the study period, resulting in 5% ceftriaxone resistance, 27% decreased susceptibility to ceftriaxone and 35% azithromycin resistance in 2017 and 11% of the isolates showing both decreased susceptibility to ceftriaxone and azithromycin resistance. Phylogenetic and cluster analysis showed the emergence and expansion in 2017 of a clonally related cluster containing strains with high abundance of decreased susceptibility to ceftriaxone and/or cefixime, which was related to the presence of the mosaic penA allele X. Co-resistance to azithromycin was also observed in this cluster. Conclusions: Our findings have major implications for the future reliability of ceftriaxone monotherapy and ceftriaxone plus azithromycin dual therapy in China.
High-level Ceftriaxone Resistance Due to Transfer of Pena Allele 60.001 into Endemic Gonococcal Lineages in Hangzhou, China.

Fan Yang,Xia Sun,Ying Fu,Feng Zhao,Xu'ai Lin,Yan Chen,Stijn van der Veen

DOI: https://doi.org/10.1093/jac/dkae297

2024-01-01

Journal of Antimicrobial Chemotherapy

Abstract:Objectives: Neisseria gonorrhoeae strains associated with the high-level ceftriaxone-resistant FC428 clone or containing its main resistance determinant, penA allele 60.001, have shown global transmission. In Hangzhou, China, 10% of the isolates were associated with the FC428 clone in 2019. Here, we investigated ceftriaxone resistance and the prevalence of FC428-associated strains in Hangzhou in 2020-22. Methods: A total of 209 gonococcal isolates were investigated for antimicrobial susceptibility to ceftriaxone and other antibiotics by agar dilution method. Sequence types and penA alleles were determined by PCR and sequence analysis. Results: Resistance to ceftriaxone (MIC > 0.125 mg/L) was observed for 16% (33/209) of the isolates, whereas 6.7% (14/209) of the isolates displayed high-level ceftriaxone resistance (MIC = 1 mg/L). These 14 high-level ceftriaxone-resistant isolates and another isolate displaying an MIC = 0.25 mg/L contained penA allele 60.001, with eight of these isolates, all from 2020 to 2021 belonging to MLST ST1903, the sequence type commonly associated with the original FC428 clone. Importantly, the six penA allele 60.001-containing isolates from 2022 belonged to MLST ST8123, ST7365 and ST7367, which are among the most frequently encountered sequence types found in China. Therefore, these results indicate that endemic lineages in China have acquired penA allele 60.001. Conclusions: Here, we report continued transmission of gonococcal strains associated with the FC428 clone or containing penA allele 60.001 in Hangzhou. A major concern for public health is the acquisition of penA allele 60.001 by successful endemic lineages, which might enhance the transmission of this high-level ceftriaxone resistance trait.
High Percentage Of The Ceftriaxone-Resistant Neisseria Gonorrhoeae Fc428 Clone Among Isolates From A Single Hospital In Hangzhou, China

Jing Yan,Yan Chen,Fan Yang,Xia Ling,Shengnan Jiang,Feng Zhao,Yunsong Yu,Stijn van der Veen

DOI: https://doi.org/10.1093/jac/dkaa526

2021-01-01

Journal of Antimicrobial Chemotherapy

Abstract:Objectives: Ceftriaxone is currently the last-remaining empirical antimicrobial therapy for treatment of gonorrhoea. However, the high-level ceftriaxone-resistant gonococcal FC428 clone has shown transmission in China in recent years. Therefore, the aim of this study was to analyse ceftriaxone resistance among a collection of recent clinical isolates, with a specific focus on prevalence of the FC428 clone.Methods: A total of 70 consecutive gonococcal isolates were collected between May and October 2019 from a single hospital in Hangzhou, China, and analysed for antimicrobial susceptibility by the agar dilution method. STs were determined by PCR and sequences and isolates related to the FC428 clone were further characterized by WGS and phylogenetic analysis.Results: Ceftriaxone resistance (MIC >0.125 mg/L) was observed in 21 (30%) isolates, while 14 (20%) isolates displayed a ceftriaxone MIC of 0.125 mg/L. Importantly, seven (10%) isolates were related to the gonococcal FC428 clone based on the presence of mosaic penA allele 60.001, displaying identical or closely related STs, and phylogenetic analysis after WGS. These seven isolates displayed high-level ceftriaxone resistance (MIC = 1 mg/L) and all associated gonorrhoea cases resulted in treatment failure because oral cephalosporins were initially prescribed. Subsequent re-treatment with a higher dose (2 g) of IV ceftriaxone appeared to be successful because all patients returning for test-of-cure became culture-negative.Conclusions: Here, we report a high percentage of the internationally spreading gonococcal FC428 clone among clinical isolates from a single hospital in Hangzhou, China. A high dose of ceftriaxone is currently the only recommended and effective therapy.
High percentage of the ceftriaxone-resistant<i>Neisseria gonorrhoeae</i>FC428 clone among isolates from a single hospital in Hangzhou, China

Jing Yan,Yan Chen,Fan Yang,Lei Xia,Shengnan Jiang,Feng Zhao,Yunsong Yu,Stijn van der Veen

DOI: https://doi.org/10.1093/jac/dkaa526

2021-01-01

Journal of Antimicrobial Chemotherapy

Abstract:Abstract Objectives Ceftriaxone is currently the last-remaining empirical antimicrobial therapy for treatment of gonorrhoea. However, the high-level ceftriaxone-resistant gonococcal FC428 clone has shown transmission in China in recent years. Therefore, the aim of this study was to analyse ceftriaxone resistance among a collection of recent clinical isolates, with a specific focus on prevalence of the FC428 clone. Methods A total of 70 consecutive gonococcal isolates were collected between May and October 2019 from a single hospital in Hangzhou, China, and analysed for antimicrobial susceptibility by the agar dilution method. STs were determined by PCR and sequences and isolates related to the FC428 clone were further characterized by WGS and phylogenetic analysis. Results Ceftriaxone resistance (MIC >0.125 mg/L) was observed in 21 (30%) isolates, while 14 (20%) isolates displayed a ceftriaxone MIC of 0.125 mg/L. Importantly, seven (10%) isolates were related to the gonococcal FC428 clone based on the presence of mosaic penA allele 60.001, displaying identical or closely related STs, and phylogenetic analysis after WGS. These seven isolates displayed high-level ceftriaxone resistance (MIC = 1 mg/L) and all associated gonorrhoea cases resulted in treatment failure because oral cephalosporins were initially prescribed. Subsequent re-treatment with a higher dose (2 g) of IV ceftriaxone appeared to be successful because all patients returning for test-of-cure became culture-negative. Conclusions Here, we report a high percentage of the internationally spreading gonococcal FC428 clone among clinical isolates from a single hospital in Hangzhou, China. A high dose of ceftriaxone is currently the only recommended and effective therapy.
Neisseria gonorrhoeae ST-1901 in Rio de Janeiro from 2006 to 2022: Phylogeny and antimicrobial resistance evolution of a well-succeeded pathogen

Raphael Cavalcante de Medeiros,Késia Thaís Barros Dos Santos,Ana Paula Ramalho Costa-Lourenço,Larissa Brasil Skaf,Adriane Meira Mercadante,Matheus Henrique Banchete Rosa,Sergio Eduardo Longo Fracalanzza,Adriana Lúcia Pires Ferreira,Jennifer L Reimche,Kim M Gernert,Ellen Neumeister Kersh,Raquel Regina Bonelli

DOI: https://doi.org/10.1016/j.ijantimicag.2024.107299

Abstract:Neisseria gonorrhoeae is a global threat to public health due to the accumulation of antimicrobial resistance mechanisms. ST-1901 is an internationally important sequence type (ST) because of its high incidence and the usual occurrence of chromosomally determined resistance. In this study, we describe the evolution of the ST-1901 and its single locus variants in Rio de Janeiro from 2006 to 2022. We analyzed 82 N. gonorrhoeae isolates according to antimicrobial susceptibility profile, resistance mechanisms, molecular typing, and phylogenetics. Six different single locus variants were detected. Phylogenetic analysis identified five clades, which share similar characteristics. Resistance rates for penicillin and tetracycline decreased due to the lower occurrence of resistance plasmids, but intermediary resistance to penicillin rose. Resistance to ciprofloxacin remained high throughout all clades and the years of the study. Regarding resistance to azithromycin, alterations in mtrR promoter and gene, and 23S rRNA encoding gene rrl were detected, with a notable rise in the incidence of C2611T mutations in more recent years occurring in four of five clades. In contrast, β-lactam resistance associated penA 34 mosaic was found only in one persisting clade (Clade D), and unique G45D and A39T mutations in mtrR gene and its promoter (Nm-Like) were found only in Clade B. Taken together, these data suggest that ST-1901, a persistently circulating lineage of N. gonorrhoeae in Rio de Janeiro, has undergone changes over the years and may evolve to develop resistance to the current recommended dual therapy adopted in Brazil, namely, ceftriaxone and azithromycin.
Genomic Epidemiology of Neisseria Gonorrhoeae in Shenzhen, China, During 2019–2020: Increased Spread of Ceftriaxone-Resistant Isolates Brings Insights for Strengthening Public Health Responses

Di Wang,Yamei Li,Chi Zhang,Yaling Zeng,Junping Peng,Feng Wang

DOI: https://doi.org/10.1128/spectrum.01728-23

IF: 3.7

2023-01-01

Microbiology Spectrum

Abstract:ABSTRACT The antimicrobial resistance (AMR) in gonorrhea poses global threat of increasing public health concern. In response to this concern, molecular surveillance has been widely utilized to detail the changes in the evolution and distribution of Neisseria gonorrhoeae during AMR transmission. In this study, we performed a comprehensive molecular surveillance of 664 N. gonorrhoeae isolates collected in Shenzhen, one of the cities with the largest mobile population in China, 2019–2020. In 2020, ceftriaxone showed an unprecedented high resistance rate of 24.87%, and 67.83% of the ceftriaxone-resistant (Cro-R) isolates harbored a nonmosaic penA allele. The Cro-R isolates with nonmosaic penA alleles showed a tremendous increasing trend from 0.00% in 2014 to 20.45% in 2020, which proves the need for monitoring nonmosaic penA-related resistance. Importantly, genotyping indicated that multilocus sequence typing ST11231 (35.71%) had a notable rate of ceftriaxone resistance, which might become the focus of future surveillance. Whole-genome sequencing analysis showed that the internationally spreading FC428 clones have circulated in Shenzhen region with typical ceftriaxone resistance (MIC ≥ 0.5 mg/L) maintained. Our surveillance combined with genomic analysis provides current information to update gonorrhea management guidelines and emphasizes that continuous AMR surveillance for N. gonorrhoeae is essential. IMPORTANCE We conducted a comprehensive molecular epidemiology analysis for antimicrobial-resistant Neisseria gonorrhoeae in Shenzhen during 2019–2020, which provided important data for personalized treatment and adjustment of monitoring strategy. Briefly, the proportion of ceftriaxone-resistant (Cro-R) isolates reached a stunning prevalence rate of 24.87% in 2020. A typical increment of Cro-R isolates with nonmosaic penA alleles proves the necessity of monitoring nonmosaic AMR mechanism and involving it into developing molecular detection methods. Whole-genome sequencing analysis showed that the international spreading FC428 clone has been circulating in Shenzhen with typical ceftriaxone resistance (MIC ≥ 0.5 mg/L) maintained. In summary, we conducted a comprehensive epidemiology study, providing significant data for therapy management. Our results not only improve the understanding of the distribution and transmission of AMR in N. gonorrhoeae but also provide effective AMR data for improving surveillance strategies in China.
Molecular characteristics of cephalosporins resistant Neisseria gonorrhoeae strains isolated from Gonococcal Antimicrobial Resistance Surveillance Program in China, 2015-2016

Jin Zhang,Xiao-Yu Zhu,Jing-Wei Liu,Shao-Chun Chen,Yue-Ping Yin

DOI: https://doi.org/10.1097/jd9.0000000000000247

2022-01-01

International Journal of Dermatology and Venereology

Abstract:Background: An increasing level of antimicrobial resistance to extended-spectrum cephalosporins (ESCs), has been reported by the China Gonococcal Antimicrobial Resistance Surveillance Program (China-GRSP). Methods: 2038 Neisseria gonorrhoeae (NG) isolates were collected from China-GRSP between 2015 and 2016. NG multiantigen sequence typing (NG-MAST), MLST (multi-locus sequence typing) and NG sequence typing for antimicrobial resistance (NG-STAR) were used to determine characteristics and resistant determinants of cephalosporins resistant isolates. Results: 74 (3.6%) cephalosporins resistant isolates were confirmed. MLSTST7363 was the most prevalent MLST among cefixime resistant (CFX-R) isolates, while MLSTST7365 (n = 8) in ceftriaxone resistant (CRO-R) isolates. And CFX-R strains mainly associated with penA-X(n = 27,44.3%), penA-XIII (n = 6,9.8%), penA-XVIII (n = 5, 8.2%), and CRO-R strains mainly related to penA-XVIII (n = 10,25.6%), penA-43(n = 9,23.1%), penA-XIII(n = 7,17.9%). Conclusion: The main conclusion of this study is that the predominant cephalosporin-resistant clones in China include locally emerged and imported linages. The CFX-R and CRO-R strains are primarily related to penA mutations and their predominant genotypes are different. With the increase of international travel, tracking high-risk resistant clones and identifying outbreaks and their association with epidemiological characteristics are critical to improve public health.
Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020

Xiaomian Lin,Xiaolin Qin,Xingzhong Wu,Yiwen Liao,Yuqi Yu,Qinghui Xie,Sanmei Tang,Chixing Guo,Junming Pei,Zhizhou Wu,Changhui Cai,Feng Wang,Shanghua Wu,Heyong Chen,Xiaofeng Liu,Ming Li,Wenling Cao,Heping Zheng

DOI: https://doi.org/10.1128/aac.02294-21

IF: 5.938

2022-04-19

Antimicrobial Agents and Chemotherapy

Abstract:The emergence of multidrug resistance in Neisseria gonorrhoeae is concerning, especially the cooccurrence of azithromycin resistance and decreased susceptibility to extended-spectrum cephalosporin. This study aimed to confirm the antibiotic resistance trends and provide a solution for N. gonorrhoeae treatment in Guangdong, China.

pharmacology & pharmacy,microbiology
Evaluation of alternative antibiotics for susceptibility of gonococcal isolates from China.

Fan Yang,Jing Yan,Jianglin Zhang,Stijn van der Veen

DOI: https://doi.org/10.1016/j.ijantimicag.2019.11.003

IF: 15.441

2019-01-01

International Journal of Antimicrobial Agents

Abstract:The efficacy of the currently recommended first-line treatments for gonococcal infections - ceftriaxone monotherapy or ceftriaxone/azithromycin dual therapy - is waning rapidly, and efficient alternative antimicrobials are needed urgently to ensure that future treatment of gonorrhoea remains available. As such, the aim of this study was to screen alternative clinically approved antimicrobials for in-vitro activity against Neisseria gonorrhoeae. The susceptibility levels of 504 clinical isolates from Zhejiang Province, China to ertapenem, tigecycline, gentamicin, fosfomycin, gemifloxacin, doxycycline and rifampicin were investigated using the agar dilution method. The presence of resistance determinants was identified by polymerase chain reaction and sequencing. The minimum inhibitory concentration inhibiting 90% of growth (MIC90) was 0.06 mg/L for ertapenem, 0.25 mg/L for tigecycline, 16 mg/L for doxycycline, 4 mg/L for gemifloxacin, 16 mg/L for gentamicin, 32 mg/L for fosfomycin and 128 mg/L for rifampicin. All strains appeared to be susceptible to tigecycline (MIC ≤0.5 mg/L), while a poor correlation between tigecycline and tetracycline susceptibility was observed, indicating that tetracycline resistance determinants have little impact on tigecycline susceptibility. For ertapenem, 30 isolates showed an MIC >0.125 mg/L, but the correlation between ertapenem and ceftriaxone susceptibility was low and only two strains showed an MIC >0.125 mg/L for both antibiotics. Therefore, it appeared that most ceftriaxone-resistant isolates were still susceptible to ertapenem. In conclusion, tigecycline and ertapenem showed good activity against N. gonorrhoeae and limited cross-resistance with previously used antibiotics. Therefore, they might be interesting candidates for further evaluation of their suitability as alternative antigonococcal therapies.
Identification of High-Level Ceftriaxone-Resistant Neisseria Gonorrhoeae Isolates with Diverse Pena Alleles in Zhejiang, China.

Lulu Zhang,Lihua Hu,Yamei Li,Leshan Xiu,Di Wang,Jia Huang,Weiming Gu,Junping Peng

DOI: https://doi.org/10.1016/j.jgar.2023.08.007

IF: 4.349

2023-01-01

Journal of Global Antimicrobial Resistance

Abstract:Objectives: The prevalence of ceftriaxone-resistant Neisseria gonorrhoeae poses a significant threat to the effectiveness of gonorrhoea treatment. The aim of the present study was to analyse the characteristics of ceftriaxone-resistant N. gonorrhoeae , with a specific focus on high-level ceftriaxone-resistant strains. Methods: A total of 207 strains of N. gonorrhoeae were collected from hospitals in Zhejiang, China, between 2019 and 2020. From this collection, we selected 8 strains of ceftriaxone-resistant N. gonorrhoeae for whole-genome sequencing, genotyping, and molecular profile analysis. For clonal strains (FC428-like), we conducted a phylogenetic analysis to understand their origin and evolutionary path. Results: Among the selected strains, 5 demonstrated high-level ceftriaxone resistance (MIC 1-2 mg/L). The genotyping results showed that these isolates had a higher diversity of penA alleles than expected. Four isolates had mosaic penA -60.001 allele and the remaining four had different non-mosaic penA alleles. Phylogenetic analysis suggested that the emergence of FC428-like clones containing penA -60.001 may result from further dissemination of different FC428 subclones from different regions of China. The identification of high-level ceftriaxone resistance in non-mosaic penA gonococci, specifically in the ZJ20-3 isolate ( penA -21.001) with an MIC of 2 mg/L, is a groundbreaking discovery. Conclusions: We present a comprehensive analysis of ceftriaxone-resistant N. gonorrhoeae isolates in Zhejiang, highlighting a significant diversity of penA alleles. The identification of strains exhibiting resistance to ceftriaxone at high levels in our study underscores the potential threat to existing protocols for gonorrhoea treatment. Consequently, we strongly emphasize the urgent need to enhance surveillance initiatives focused on ceftriaxone-resistant N. gonorrhoeae . (c) 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
Identification of Ceftriaxone-Resistant Neisseria Gonorrhoeae FC428 Clone and Isolates Harboring a Novel Mosaic Pena Gene in Chengdu in 2019–2020

Di Wang,Youwei Wang,Yamei Li,Leshan Xiu,Gang Yong,Yang,Weiming Gu,Junping Peng

DOI: https://doi.org/10.1186/s12941-023-00614-x

2023-01-01

Annals of Clinical Microbiology and Antimicrobials

Abstract:Abstract Background Antimicrobial resistance in gonorrhea has become a growing global public health burden. Neisseria gonorrhoeae isolates with resistance to ceftriaxone, the last remaining first-line option, represent an emerging threat of untreatable gonorrhea. Methods A total of ten ceftriaxone-resistant N. gonorrhoeae FC428 isolates and two isolates harboring a novel mosaic penA-232.001 allele from 160 gonococcal isolates in Chengdu in 2019–2020 was described in the present study. Multilocus sequence typing (MLST) and N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were performed to characterize the isolates. Whole genome sequencing and maximum-likelihood method were performed to infer how the genetic phylogenetic tree of these isolates looks like. Recombination analysis was performed using the RDP4 software. This study was registered in the Chinese Clinical Trial Registry (ChiCTR2100048771, registration date: 20210716). Results The genetic phylogeny showed that the ten FC428 isolates sporadically clustered into different phylogenetic clades, suggesting different introductions and local transmission of FC428. Two isolates showed close genetic relatedness to ceftriaxone-resistant clone A8806, which was only reported from Australia in 2013. Homologous recombination events were detected in penA between Neisseria gonorrhoeae and commensal Neisseria species (N. perflava and N. polysaccharea), providing evidence of commensal Neisseria species might serve as reservoirs of ceftriaxone resistance-mediating penA sequences in clinical gonococcal strains. Conclusions Our results demonstrate further dissemination of FC428 in China and resurgence risks of sporadic ceftriaxone-resistant A8806 to become the next clone to spread.
Antibiotic Resistance and Treatment Options for Multidrug-Resistant Gonorrhea

Fan Yang,Jing Yan,Stijn van der Veen

DOI: https://doi.org/10.1097/im9.0000000000000024

2020-01-01

Infectious Microbes & Diseases

Abstract:Gonorrhea is a sexually transmitted disease with a high global incidence. Its causative agent, Neisseria gonorrhoeae, has shown a remarkable flexibility to adapt and become resistant to all antimicrobials introduced over the past century for gonococcal therapy. The currently last available first-line therapy that is recommended in most countries is ceftriaxone. However, resistance levels against ceftriaxone are rising globally and incidences of confirmed treatment failure are increasingly encountered, particularly with the global spreading of the ceftriaxone-resistant FC428 clone in recent years. Resistance against most antimicrobials has been the result of adaptive genomic mutations that reduce affinity of the antimicrobial to its target protein or rRNA, although most multidrug-resistant strains also appear to have an upregulated multidrug efflux pump. To ensure gonococcal treatment remains available in the future, alternative therapies are urgently needed. Therefore, both alternative clinically approved antimicrobials and novel antimicrobials have been intensely studied both in gonococcal susceptibility analyses and clinical efficacy trials. Although there have been some limited successes, all studied alternative therapies that reached clinical trials have displayed some shortcomings in their efficacy against pharyngeal infections and/or overlapping resistance determinants with previously or currently used antimicrobials. This review summarizes the development of gonococcal antimicrobial resistance over the past century, describes the mechanisms involved in antimicrobial resistance, and provides an overview of the alternative therapies that have been under investigation this past decade.
Tuberculosis — United States, 2023

Paula M. Williams,Robert H. Pratt,William L. Walker,Sandy F. Price,Rebekah J. Stewart,Pei-Jean I. Feng

DOI: https://doi.org/10.15585/mmwr.mm7312a4

2024-03-30

MMWR Morbidity and Mortality Weekly Report

Abstract:This report describes increases in the prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae in China.

public, environmental & occupational health
Adaptability analysis of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China

Yamei Li,Yang Yang,Wenling Cao,Leshan Xiu,Di Wang,Wanyi Gu,Junping Peng

DOI: https://doi.org/10.21203/rs.3.rs-3025144/v1

2023-01-01

Abstract:Abstract We describe nine internationally spreading ceftriaxone-resistant FC428 clone-related Neisseria gonorrhoeae strains with a typical ceftriaxone-resistant phenotype (MIC ≥ 0.5 mg/L) isolated from Guangzhou and Shanghai between 2019 and 2020. The adaptability analysis further involved all FC428-related N. gonorrhoeae strains reported in China and our data demonstrated that three representative clones (MLST-ST1903_NG-STAR-ST1143, MLST-ST1600_NG-STAR-ST2208, and MLST-ST13943_NG-STAR-ST233) were observed to settle in China in evolution. Specifically, enhancing antimicrobial resistance surveillance of the three representative clones is crucial for understanding the transmission trajectory and optimizing therapy strategies.
Surveillance and molecular epidemiology of Neisseria gonorrhoeae isolates in Shenzhen, China, 2010–2017

Feng Wang,Jing-Wei Liu,Yi-Zhun Li,Li-Jun Zhang,Jing Huang,Xiang-Sheng Chen,Shao-Chun Chen,Yue-Ping Yin

DOI: https://doi.org/10.1016/j.jgar.2020.08.013

IF: 4.349

2020-12-01

Journal of Global Antimicrobial Resistance

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Development and emergence of resistance in <em>Neisseria gonorrhoeae</em> (NG) to antimicrobials have become a major public health problem worldwide. The aim of our study was to analyze antimicrobial susceptibility and molecular characteristics of NG isolates in Shenzhen.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>A total of 1,282 NG isolates were consecutively collected between 2010 and 2017. The demographic information of patients was also collected. Minimum inhibitory concentrations of ceftriaxone, spectinomycin, ciprofloxacin, azithromycin and penicillin were determined using the agar dilution method. Isolates were genotyped using <em>Neisseria gonorrhoeae</em> multi-antigen sequence typing (NG-MAST).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Among the isolates, 97.4% were resistant to ciprofloxacin and 68.2% were resistant to penicillin. 5.0% showed decreased susceptibility to ceftriaxone (CRO<sup>D</sup>), and 17.3% were resistant to azithromycin (AZM-R), in addition, 1.3% were simutaneously CRO<sup>D</sup> and AZM-R. All isolates were susceptible to spectinomycin. Increasing MICs of ceftriaxone was found from 2010-2017. 427 sequence types (STs) and 68 genogroups were identified from 724 isolates. ST5061, ST3741 and ST1766 were observed across the study years. The predominant type were ST14638 (n = 3) among 32 CRO<sup>D</sup> isolates. Prevalent STs were ST5061 (n = 6), ST1866 (n = 5), ST11133 (n = 5) among 96 AZM-R isolates.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>High prevalence of isolates resistant to ciprofloxacin and penicillin were found in our study. Azithromycin, one antimicrobial of dual antimicrobial therapy recommended by WHO, showed high prevalence of resistance. The other one, ceftriaxone, can be used continuously in this region due to lower lever of resistance. However, the emergence of CRO<sup>D</sup> and descending susceptibility to ceftriaxone indicate that continuous surveillance of antimicrobial resistance is essential.</p>

pharmacology & pharmacy,infectious diseases
Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities

Yiwen Liao,Qinghui Xie,Xiaoxiao Li,Xiaona Yin,Xingzhong Wu,Mingjing Liu,Yuying Pan,Lihong Zeng,Jianjiang Yang,Zhanqin Feng,Xiaolin Qin,Heping Zheng

DOI: https://doi.org/10.1186/s12941-023-00587-x

2023-05-17

Abstract:Background: Antimicrobial resistance (AMR) of untreatable gonococcal infection is an emerging threat, especially in Guangdong, a prosperous province in Southern China. Methods: N.gonorrhoeae was isolated from 20 cities in Guangdong and determined antimicrobial susceptibility. Through whole-genome sequencing (WGS), multilocus sequence typing (MLST), N.gonorrhoeae multiantigen sequence typing (NG-MAST), and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were obtained based on the PubMLST database ( https://pubmlst.org/ ). Phylogenetic analysis was used for dissemination and tracking analysis. Results: Antimicrobial susceptibility was performed on 347 isolates, and 50 isolates were identified as decreased susceptibility (DS) to cephalosporins. Of which 16.0% (8/50) were ceftriaxone DS, 38.0% (19/50) were cefixime DS, and 46.0% (23/50) were both ceftriaxone and cefixime DS. In all, the dual-resistant rate of the cephalosporin-DS isolates was 96.0% for penicillin and 98.0% for tetracycline-resistant, and 10.0% (5/50) were resistant to azithromycin. All cephalosporin-DS isolates were resistant to ciprofloxacin but sensitive to spectinomycin. The predominant MLSTs were ST7363 (16%, 8/50), ST1903 (14%, 7/50), ST1901 (12%, 6/50), and ST7365 (10%, 5/50). Besides some isolates that failed genotyping (NA), NG-STAR ST1143 (n = 6) and NG-MAST ST17748 (n = 4) were the most prevalent. Twelve isolates with mosaic penA-60.001 allele retained the most elevated cephalosporin MIC (Minimum Inhibitory Concentration). Phylogenetic analysis revealed that epidemic penA-60.001 clones, either domestic or foreign, had spread to nine cities in Guangdong, and 9/12 clones were from the Pearl River Delta region. Conclusions: N. gonorrhoeae with cephalosporins-DS was extensively disseminated in Guangdong, Southern China, requiring strict surveillance.
National Epidemiology of Carbapenem-Resistant and Extensively Drug-Resistant Gram-negative Bacteria Isolated from Blood Samples in China in 2013.

A. Xu,B. Zheng,Y-C. Xu,Z-G. Huang,N-S. Zhong,C. Zhuo

DOI: https://doi.org/10.1016/j.cmi.2015.09.015

IF: 13.31

2016-01-01

Clinical Microbiology and Infection

Abstract:Although antimicrobial resistance poses a great challenge to clinicians in China, there are limited antimicrobial resistance data on Gram-negative bacteria nationwide. We investigated the phenotypic characteristics of carbapenem-resistant Escherichia coli (CREC) and Klebsiella pneumoniae (CRKP) as well as extensively drug-resistant strains of Pseudomonas aeruginosa (XDRPA) and Acinetobacter baumannii (XDRAB) isolated from blood cultures in China. Data were collected on 24113 isolates from the China surveillance of antimicrobial resistance program in 2013, which comprised 208 hospitals located in all seven administrative regions of China. Minimum inhibitory concentrations (MICs) for common antimicrobials were determined by commercial automated systems available at local hospitals, and associations with geographic and clinical distributions was further studied. The overall prevalence of CREC, CRKP, XDRAB and XDRPA strains was 1.0, 5.5, 13.7 and 4.2%, respectively. Except for CREC, which did not differ greatly by region, the prevalence of the remaining three strains varied significantly across regions. The highest prevalence of CRKP (10.6%) and XDRAB (13.1%) were found in the pediatric group, and higher prevalence of all four target strains was found in the intensive care unit. For imipenem, 55.8% of CREC and 22.9% of CRKP strains had MICs of ≤4 μg/mL, while 97.4% XDRAB and 84% XDRPA isolates had MICs of ≥16 μg/mL. All CREC, CRKP and 81.2% of XDRAB strains were susceptible to tigecycline, with MIC90 values of 0.5, 2 and 4 μg/mL, respectively. In conclusion, a high prevalence of CRKP and XDRAB has emerged in China, especially in children and in the intensive care unit.
Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015 to 2024; an observational study

Helen Fifer,Michel Doumith,Luciana Rubinstein,Laura Mitchell,Mark Wallis,Selena Singh,Gurmit Jagjit Singh,Michael Rayment,John Evans-Jones,Alison Blume,Olamide Dosekun,Kenny Poon,Achyuta Nori,Michaela Day,Rachel Pitt,Suzy Sun,Prarthana Narayanan,Emma Callan,Anna Vickers,Jack Minshull,Kirsty Bennet,James Johnson,Sarah Alexander,Hamish Mohammed,Neil Woodford,Katy Sinka,Michelle Cole

DOI: https://doi.org/10.1101/2024.08.12.24311674

2024-08-17

Abstract:Background Since June 2022, there has been a rise in the number of ceftriaxone resistant Neisseria gonorrhoeae cases detected in England (n = 15), of which one third were extensively-drug resistant (XDR). We describe the demographic and clinical details of the recent cases and investigate the phenotypic and molecular characteristics of the isolates. For a comprehensive overview, we also reviewed 16 ceftriaxone-resistant cases previously identified in England since December 2015 and performed a global genomic comparison of all publicly available ceftriaxone-resistant N. gonorrhoeae strains with mosaic penA alleles. Methods All N. gonorrhoeae isolates resistant to ceftriaxone (MIC >0.125 mg/L) were whole-genome sequenced and compared with 142 global sequences of ceftriaxone-resistant N. gonorrhoeae. Demographic, behavioural, and clinical data were collected, including treatment and outcomes. Results All cases were heterosexuals, and most infections were associated with travel to or from the Asia-Pacific region. However, some had not travelled outside England within the previous few months. There were no ceftriaxone genital treatment failures, but 3/5 pharyngeal infections and the only rectal infection failed treatment. The isolates represented 13 different multi-locus sequence types (MLSTs), and most had the mosaic penA-60.001 allele. The global genomes clustered into eight major phylogroups, with regional associations. All XDR isolates belonged to the same phylogroup, represented by MLST 16406. Conclusion Ceftriaxone resistance in N. gonorrhoeae continues to be associated with the penA-60.001 allele within multiple genetic backgrounds and with widespread dissemination in the Asia-Pacific region. Heightened surveillance activities have been initiated to detect further cases with the aim of interrupting further transmission.

Sexual and Reproductive Health
Antimicrobial Resistance and Molecular Characteristics among Neisseria Gonorrhoeae Clinical Isolates in A Chinese Tertiary Hospital.

Zhou Zheng,Li Liu,Xiaofei Shen,Jingyi Yu,Lijiang Chen,Lingling Zhan,Han Chen,Chunchan Lin,Ye Jiang,Hong Xia,Liangxing Wang,Fangyou Yu

DOI: https://doi.org/10.2147/idr.s221109

2019-01-01

Infection and Drug Resistance

Abstract:PURPOSE:The resistance of N. gonorrhoeae to antimicrobial agents has been increasing year by year due to the overuse of antibiotics. The primary aims of the present study were to investigate the molecular characteristics of the clinical isolates of Neisseria gonorrhoeae and the resistance to azithromycin in a Chinese tertiary hospital.METHODS:From January 2014 to May 2017, a total of 55 clinical isolates of N. gonorrhoeae were collected. Genes associated with azithromycin resistance (AZM-R), including mutations in 23S rRNA alleles, the mtrR promoter and coding regions, and rplD and rplV were evaluated by PCR and DNA sequencing. All clinical isolates were subjected to N. gonorrhoeae multiantigen sequence typing (NG-MAST), while the AZM-R isolates were further characterized by multilocus sequence typing (MLST).RESULTS:The AZM-R rate in this study was 23.64% (13/55), and a single (A)-nucleotide deletion mutation in the mtrR promoter region, a G45D mutation in the mtrR coding region, a point mutation in rplD, and an A2047G mutation in 23S rRNA alleles were detected in 13, 4, 3 and 4 isolates, respectively; no mutations were found in rplV. There was no significant difference in the mtrR coding region mutation rate between the azithromycin-sensitive and AZM-R groups (P > 0.05); however, there was a significant difference in the mutation rate of the mtrR promoter region (P < 0.05). Among the 55 isolates studied, 43 distinct NG-MAST were determined, while the AZM-R isolates were allocated into 10 distinct MLST/NG-MAST combinations. All three isolates with high-level AZM-R belonged to the sequence types (STs) NG-MAST ST1866 and MLST ST10899.CONCLUSION:N. gonorrhoeae clinical isolates from Wenzhou, eastern China, showed considerable genetic diversity. Measures should be implemented to monitor the spread of the NG-MAST ST1866 and MLST ST10899 N. gonorrhoeae clones, which exhibit high-level AZM-R in eastern China.
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone

Sai Li,Xiao-Hong Su,Wen-Jing Le,Fa-Xing Jiang,Bao-Xi Wang,Peter A Rice

DOI: https://doi.org/10.1186/s12879-014-0622-0

2014-11-27

Abstract:Background: Evolving gonococcal antimicrobial resistance (AMR) poses a serious threat to public health. The aim of this study was to: update antimicrobial susceptibility data of Neisseria gonorrhoeae recently isolated in Nanjing, China and identify specific deteminants of antimicrobial resistance and gentoypes of isolates with decreased sensitivity to ceftriaxone. Methods: 334 N. gonorrhoeae isolates were collected consecutively from symptomatic men attending the Nanjing STD Clinic between April 2011 and December 2012. The minimum inhibitory concentrations (MICs) for penicillin, tetracycline, ciprofloxacin, spectinomycin and ceftriaxone were determined by agar plate dilution for each isolate. Penicillinase-producing N. gonorrhoeae (PPNG) and tetracycline-resistant N. gonorrhoeae (TRNG) were examined and typed for β-lactamase and tetM encoding plasmids respectively. Isolates that displayed elevated MICs to ceftriaxone (MIC ≥0.125 mg/L) were also tested for mutations in penA, mtrR, porB1b, ponA and pilQ genes and characterized by Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST). Results: 98.8% (330/334) of N. gonorrhoeae isolates were resistant to ciprofloxacin; 97.9% (327/334) to tetracycline and 67.7% (226/334) to penicillin. All isolates were susceptible to ceftriaxone (MIC ≤0.25 mg/L) and spectinomycin (MIC ≤32 mg/L). Plasmid mediated resistance was exhibited by 175/334 (52%) of isolates: 120/334 (36%) of isolates were PPNG and 104/334 (31%) were TRNG. 90.0% (108/120) of PPNG isolates carried the Asia type β-lactamase encoding plasmid and 96% (100/104) of TRNG isolates carried the Dutch type tetM containing plasmid. Elevated MICs for ceftriaxone were present in 15 (4.5%) isolates; multiple mutations were found in penA, mtrR, porB1b and ponA genes. The 15 isolates were distributed into diverse NG-MAST sequence types; four different non-mosaic penA alleles were identified, including one new type. Conclusions: N. gonorrhoeae isolates in Nanjing generally retained similar antimicrobial resistance patterns to isolates obtained five years ago. Fluctuations in resistance plasmid profiles imply that genetic exchange among gonococcal strains is ongoing and is frequent. Ceftriaxone and spectinomycin remain treatments of choice of gonorrhea in Nanjing, however, decreased susceptibility to ceftriaxone and rising MICs for spectinomycin of N. gonorrhoeae isolates underscore the importance of maintaining surveillance for AMR (both phenotypic and genotypic).

Ceftriaxone-Resistant Gonorrhea — China, 2022

Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17).

High-level Ceftriaxone Resistance Due to Transfer of Pena Allele 60.001 into Endemic Gonococcal Lineages in Hangzhou, China.

High Percentage Of The Ceftriaxone-Resistant Neisseria Gonorrhoeae Fc428 Clone Among Isolates From A Single Hospital In Hangzhou, China

High percentage of the ceftriaxone-resistant<i>Neisseria gonorrhoeae</i>FC428 clone among isolates from a single hospital in Hangzhou, China

Neisseria gonorrhoeae ST-1901 in Rio de Janeiro from 2006 to 2022: Phylogeny and antimicrobial resistance evolution of a well-succeeded pathogen

Genomic Epidemiology of Neisseria Gonorrhoeae in Shenzhen, China, During 2019–2020: Increased Spread of Ceftriaxone-Resistant Isolates Brings Insights for Strengthening Public Health Responses

Molecular characteristics of cephalosporins resistant Neisseria gonorrhoeae strains isolated from Gonococcal Antimicrobial Resistance Surveillance Program in China, 2015-2016

Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020

Evaluation of alternative antibiotics for susceptibility of gonococcal isolates from China.

Identification of High-Level Ceftriaxone-Resistant Neisseria Gonorrhoeae Isolates with Diverse Pena Alleles in Zhejiang, China.

Identification of Ceftriaxone-Resistant Neisseria Gonorrhoeae FC428 Clone and Isolates Harboring a Novel Mosaic Pena Gene in Chengdu in 2019–2020

Antibiotic Resistance and Treatment Options for Multidrug-Resistant Gonorrhea

Tuberculosis — United States, 2023

Adaptability analysis of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China

Surveillance and molecular epidemiology of Neisseria gonorrhoeae isolates in Shenzhen, China, 2010–2017

Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities

National Epidemiology of Carbapenem-Resistant and Extensively Drug-Resistant Gram-negative Bacteria Isolated from Blood Samples in China in 2013.

Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015 to 2024; an observational study

Antimicrobial Resistance and Molecular Characteristics among Neisseria Gonorrhoeae Clinical Isolates in A Chinese Tertiary Hospital.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone